EMA human medicine committee recommends approval of Sanofi’s Sarclisa to treat transplant-ineligible newly diagnosed multiple myeloma: Paris Saturday, November 16, 2024, 09:00 H ...
Health stocks slumped on Friday as Wall Street weighed the impact that prominent vaccine skeptic Robert F. Kennedy Jr. could ...
Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty ...
Vaccine makers hit hardest as Robert F. Kennedy Jr. appointment to Department of Health raises concerns for US drug market.
Scientists Fear A New Thalidomide If RFK Jr. Is Allowed To ‘Go Wild’ With Crank Health Theories.
“I don’t want to have to see us go backward in order to remind ourselves ... fell just over 2%. French drug company Sanofi, ...
GlobalData on MSN23h
FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticariaThe FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.
Europe's STOXX 600 fell on Friday, dragged by technology and healthcare stocks, keeping the index on track for its fourth ...
AstraZeneca and GSK fell as the president-elect named Kennedy as his pick for the role overseeing the US's rules on medicine, ...
The intersection at Mitchell Avenue and the Belt Highway will see construction starting on Monday, Nov. 18. Missouri American ...
ABC News’ Phil Lipof speaks with law professor Anya Prince on how 23andMe’s recent layoffs and shuttering of its drug ...
EUROPEAN shares slipped on Friday, weighed down by disappointing earnings, concerns about the impact of US President-elect ...
The MHRA has approved Novavax’s updated Nuvaxovid vaccine for the latest subvariant in individuals aged 12 and older. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback